constipation due to semaglutide Ozempic Constipation: 10 Natural Ways Get Relief Ozempic (semaglutide) is a GLP-1

Companies such as Hengrui, Hansoh Pharmaceutical and others are now advancing their own obesity assets, not only for the domestic market but with ambitions beyond China

However, everyone will respond differently to Ozempic

Together, we can navigate the complexities of your health and help you embrace a more vibrant, comfortable, and healthy future

Clinical Trial Results The clinical trial SURMOUNT-5 (NCT05822830) of adults with obesity who did not have type 2 diabetes demonstrated that Zepbound patients had an average weight loss of 50.3 lbs (22.8 kg), which was 20.2% of their body weight, and a 7.2-inch ( 18.4 cm) reduction in waist circumference, at 72 weeks